Avidity Biosciences
RNA
#1835
Rank
โ‚ฌ9.27 B
Marketcap
61,52ย โ‚ฌ
Share price
0.13%
Change (1 day)
76.59%
Change (1 year)

EPS for Avidity Biosciences (RNA)

EPS in 2025 (TTM): -3,71ย โ‚ฌ

According to Avidity Biosciences's latest financial reports the company's current EPS (TTM) is -3,59ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,48ย โ‚ฌ.

EPS history for Avidity Biosciences from 2020 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,71ย โ‚ฌ49.44%
2024-2,48ย โ‚ฌ
2022-2,86ย โ‚ฌ-9.02%
2021-3,14ย โ‚ฌ68.93%
2020-1,86ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
PTC Therapeutics
PTCT
8,25ย โ‚ฌ-329.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-43,21ย โ‚ฌ 1,103.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-2,35ย โ‚ฌ-34.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
1,55ย โ‚ฌ-143.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-1,13ย โ‚ฌ-68.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,48ย โ‚ฌ-141.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,09ย โ‚ฌ-186.03%๐Ÿ‡ฌ๐Ÿ‡ง UK